Poggiolini et al., 2013 - Google Patents

Prion protein misfolding, strains, and neurotoxicity: an update from studies on mammalian prions

Poggiolini et al., 2013

View PDF @Full View
Document ID
736589615031994161
Author
Poggiolini I
Saverioni D
Parchi P
Publication year
Publication venue
International journal of cell biology

External Links

Snippet

Prion diseases, also known as transmissible spongiform encephalopathies (TSEs), are a group of fatal neurodegenerative disorders affecting humans and other mammalian species. The central event in TSE pathogenesis is the conformational conversion of the cellular prion …
Continue reading at onlinelibrary.wiley.com (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4711—Alzheimer's disease; Amyloid plaque core protein
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2828—Prion diseases
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/28—Neurological disorders
    • G01N2800/2814—Dementia; Cognitive disorders
    • G01N2800/2821—Alzheimer
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4713—Autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus; Autoantigens

Similar Documents

Publication Publication Date Title
Poggiolini et al. Prion protein misfolding, strains, and neurotoxicity: an update from studies on mammalian prions
Cobb et al. Prion diseases and their biochemical mechanisms
Aguzzi et al. Insights into prion strains and neurotoxicity
Collinge Molecular neurology of prion disease
Scialò et al. Prion and prion-like protein strains: deciphering the molecular basis of heterogeneity in neurodegeneration
Lawson et al. Prion protein glycosylation
Collinge Mammalian prions and their wider relevance in neurodegenerative diseases
Ugalde et al. Pathogenic mechanisms of prion protein, amyloid‐β and α‐synuclein misfolding: The prion concept and neurotoxicity of protein oligomers
Capellari et al. Genetic Creutzfeldt–Jakob disease and fatal familial insomnia: insights into phenotypic variability and disease pathogenesis
Mallucci et al. Rational targeting for prion therapeutics
Marín-Moreno et al. Transmission and replication of prions
Haïk et al. Biochemical and strain properties of CJD prions: complexity versus simplicity
Candreva et al. Interactions between soluble species of β-amyloid and α-Synuclein promote oligomerization while inhibiting fibrillization
Hill et al. Prion strains and species barriers
Manka et al. Prion strains viewed through the lens of cryo-EM
Obata et al. Detection of Amyloid β Oligomers with RNA Aptamers in AppNL-GF/NL-GF Mice: A Model of Arctic Alzheimer’s Disease
Zerr et al. Creutzfeldt–Jakob disease and other prion diseases
Vadukul et al. α-Synuclein aggregation is triggered by oligomeric amyloid-β 42 via heterogeneous primary nucleation
Mastrianni Prion diseases
Kotarba et al. Fine mapping of the amyloid β-protein binding site on myelin basic protein
Takahashi et al. Characterization of antibodies raised against bovine-PrP-peptides
Yuan et al. Accessibility of a critical prion protein region involved in strain recognition and its implications for the early detection of prions
Mehra et al. Convergent generation of atypical prions in knock-in mouse models of genetic prion disease
Hackl et al. Prion protein—Semisynthetic prion protein (PrP) variants with posttranslational modifications
Hill et al. Strain variations and species barriers